GOVERNEUR, N.Y. – Kinney Drugs has now opened both walk-ins and appointments for a second dose of seasonal COVID-19 vaccine for eligible individuals. In October, the CDC recommended that individuals aged 65 and older and those who are moderately to severely immunocompromised receive a second dose of seasonal COVID-19 vaccine two to six months after their last dose.
Patients in one or both groups who were vaccinated against COVID in the fall may now be due for a second dose. Kinney Drugs accepts walk-ins; however, appointments are encouraged to ensure the promptest service. The COVID-19 vaccine can be co-administered with all other approved vaccines.
“CDC data show the importance of vaccination to protect people who are most at risk for severe outcomes of COVID, such as older adults and anyone with an immunocompromising condition,” said John Marraffa, president of Kinney Drugs. “We know that vaccination can restore and enhance protection against those viruses that are causing infections and hospitalizations in our region, including RSV, COVID, and influenza. And flu is spiking right now, especially in older populations. So, if patients haven’t received their flu vaccine, it’s not too late for this year. As always, our pharmacists stand ready to assist with immunizations and other healthcare needs,” he added.
Kinney Drugs expands COVID-19 vaccine access for high-risk individuals
Patients in one or both groups who were vaccinated against COVID in the fall may now be due for a second dose.
Latest
Tadrus takes helm as NCPA president
Christian Tadrus leads NCPA in 2026-2027, urging independent pharmacists to shape pharmacy practice, regulation and payment.
From the CDR archives: Mike Wysong on pharmacy’s future
A look back at CDR’s coverage of Mike Wysong and his views on leadership, advocacy, community pharmacy and the future of patient care.
Analysis: A new era begins for NACDS under Wysong
Mike Wysong will succeed Steve Anderson as NACDS president and CEO in 2027, as the association expands pharmacy’s role in care and strengthens its economic foundation.
Wysong named CEO of NACDS
He has guided CARE Pharmacies' growth to a cooperative of more than 170 pharmacies across 28 states with sales approaching $2 billion.